CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value

$6.03−0.24 (-3.83%)

Close on Nov 13, 2026Market cap $301.78MP/E –Yield –

Earnings

CapsoVision's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Mar 25, 2027

Q4 FY2026 · estimated, during market hours

Revenue, Q3 FY2026

$3.60M

+2.9% on a year earlier

EPS, Q3 FY2026

-$0.15

Latest guidance

None

No outlook given in releases

Quarterly results

Revenue and earnings per share from each of CapsoVision's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q4 FY2026ended Dec 31, 2026	Mar 25, 2027Expected	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 12, 2026after the close	$3.60M	+2.9%	-$0.15	Release
Q2 FY2026ended Jun 30, 2026	Aug 13, 2026during market hours	$3.60M	+9.1%	–	Release
Q1 FY2026ended Mar 31, 2026	May 14, 2026during market hours	$2.80M	–	-$0.15	Release
Q4 FY2025ended Dec 31, 2025	Mar 26, 2026during market hours	$3.90M	–	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 13, 2025during market hours	$3.50M	–	–	Release
Q2 FY2025ended Jun 30, 2025	Aug 14, 2025during market hours	$3.30M	–	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

CapsoVision has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When CapsoVision puts a forecast in an earnings release, it is listed here with the exact sentence.